Antibiotic Resistance in Adult Patients with Urinary Tract Infection due to Escherichia Coli

Saeeda Nabat ul  Hassan; Khushbu  Farva; Ghulam Asghar  Bhutta; Rabia Naseer  Khan; Sadia  Zia; Usman  Ali

doi:10.51253/pafmj.v76i2.11764

Authors

Saeeda Nabat ul Hassan Department of Pathology, Sahara Medical College, Narowal Pakistan
Khushbu Farva Department of Pathology, Sahara Medical College, Narowal Pakistan
Ghulam Asghar Bhutta Department of Pathology, Sahara Medical College, Narowal Pakistan
Rabia Naseer Khan Department of Pathology, Shahida Islam Medical College, Lodhran Pakistan
Sadia Zia Department of Pathology, Avicenna Medical College, Lahore Pakistan
Usman Ali Department of Pathology, Shahida Islam Medical College, Lodhran Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76i2.11764

Keywords:

Antibiotic Sensitivity, Escherichia Coli, Multi Drug Resistance, Urinary Tract Infection

Abstract

Objective: To determine emerging antibiotic resistance of Escherichia Coli among isolated from the patients with urinary tract infection.

Study Design: Cross-sectional study.

Place and Duration of Study: Pathology Department, Sahara Medical College, Narowal Pakistan, from Mar to Aug 2022.

Methodology: Two hundred cases of multi drug resistance urinary tract infection (UTI) were studied, and E. coli was isolated in their urine specimen. Cases of either gender were included with age >15 years. Data of the patients was documented on a proforma regarding demographic data, WBC count, urine culture and antibiotic susceptibility pattern result of the isolated pathogen. After detection of the pathogen (E. coli), antibiotic susceptibility patter was determined using Kirby Bauer disc diffusion method on Mueller Hinton agar. Antibiotic susceptibility of E. coli was determined against commonly used antibiotics.

Results: In our study, multidrug resistant Escherichia Coli (E. coli) was detected in 139(69.5%) cases. There were 78(39.0%) males and 122(61.8%) females. Age of the patients ranged from 14-65 years, with a mean age of 33.4±9.1 years. One hundred and seventy-one (85.5%) cases were resistant to cephalosporins, 173(86.5%) to quinolones, 86(43.0%) to aminoglycosides, and 27(13.5%) were resistant to carbapenems.

Conclusion: Multidrug resistant E. coli infection is common among patients with urinary tract infection. E. coli was resistant to most of the commonly used antibiotics, but it showed good sensitivity to carbipenems, penicillins and amikacin.

Downloads

Download data is not yet available.

References

1. Finucane TE. “Urinary tract infection”—requiem for a heavyweight. J Am Geriat Soci 2017; 65(8): 1650-1655.

https://doi.org/10.1111/jgs.14907

2. Masajtis-Zagajewska A, Nowicki M. New markers of urinary tract infection. Clin Chim Act 2017; 471: 286-291.

https://doi.org/10.1016/j.cca.2017.06.003

3. Santhoshkumar J, Kumar SV, Rajeshkumar S. Synthesis of zinc oxide nanoparticles using plant leaf extract against urinary tract infection path ogen. Resour-Effic Tech 2017; 3(4): 459-465.

https://doi.org/10.1016/j.reffit.2017.05.001

4. Okarska-Napierała M, Wasilewska A, Kuchar E. Urinary tract infection in children: Diagnosis, treatment, imaging–Comparison of current guidelines. J Pediat Urol 2017; 13(6): 567-573. https://doi.org/10.1016/j.jpurol.2017.07.018

5. Sihra N, Goodman A, Zakri R, Sahai A, Malde S. Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol 2018; 15(12): 750-776.

https://doi.org/10.1038/s41585-018-0106-x

6. Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obs Gyne 2018; 219(1): 40-51.

https://doi.org/10.1016/j.ajog.2017.12.231

7. Forsyth VS, Armbruster CE, Smith SN, Pirani A, Springman AC, Walters MS, et al. Rapid growth of uropathogenic Escherichia Coli during human urinary tract infection. MBio 2018; 9(2).

https://doi.org/10.1128/mbio.00186-18

8. Parajuli NP, Maharjan P, Parajuli H, Joshi G, Paudel D, Sayami S. High rates of multidrug resistance among uropathogenic Escherichia Coli in children and analyses of ESBL producers from Nepal. Antimicro Resist Infect Cont 2017; 6(1): 1-7.

https://doi.org/10.1186/s13756-016-0168-6

9. Ullah A, Shah SR, Almugadam BS, Sadiqui S. Prevalence of symptomatic urinary tract infections and antimicrobial susceptibility patterns of isolated uropathogens in kohat region of Pakistan. MOJ Biol Med 2018; 3(4): 85-89.

http://dx.doi.org/10.15406/mojbm.2018.03.00082

10. Gupta K, Grigoryan L, Trautner B. Urinary tract infection. Ann Inter Med 2017; 167(7): ITC49-64.

https://doi.org/10.7326/AITC201710030

11. Byron JK. Urinary tract infection. Vet Clin North Am Small Anim Pract 2019; 49(2): 211-221.

https://doi.org/10.1016/j.cvsm.2018.11.005

12. Storme O, Tiran SJ, Garcia-Mora A, Dehesa-Dávila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Therap Adv Urol 2019; 11: 1756287218814382.

https://doi.org/10.1177/1756287218814382

13. Yerega DA, Woldeamanuel Y, Yihenew G, Gize A. Bacterial profile and antibiotic susceptibility pattern of urinary tract infection among children attending Felege Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia. Infect Drug Resist 2019; 12(1): 3575. https://dx.doi.org/10.2147%2FIDR.S217574

14. Leung AK, Wong AH, Leung AA, Hon KL. Urinary tract infection in children. Recent Pat Inflamm Allergy Drug Discov 2019; 13(1): 2-18.

https://doi.org/10.2174/1872213X13666181228154940

15. Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Amirmoezi F, Zare S. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine 2017; 96(37).

https://dx.doi.org/10.1097%2FMD.0000000000007834

16. Noor U, Suliman M, Shams H, Sultan A, Khan SH. Prevalence and Phenotypic Detection of Carbapenem and Multi Drug Resistant of E. coli in Urinary Tract Infection Patients in District Swat: Detection of Carbapenem and Multi Drug Resistant of E. coli. Pak J Health Sci 2022: 243-247.

https://doi.org/10.54393/pjhs.v3i06.367

17. Singh S, Sahu C, Patel SS, Singh A, Yaduvanshi N. A Comparative In Vitro Sensitivity Study of “Ceftriaxone–Sulbactam–EDTA” and Various Antibiotics against Gram-negative Bacterial Isolates from Intensive Care Unit. Ind Soci Crit Care Med 2020; 24(12): 1213.

https://dx.doi.org/10.5005%2Fjp-journals-10071-23573

18. Rehman MJ, Alrowaili M, Rauf AW, Eltom EH. Ceftriaxone Drug Utilization Evaluation (DUE) at Prince Abdulaziz Bin Moussae’ed Hospital, Arar, Kingdom of Saudi Arabia. Sud J Med Sci 2019; 14(4): 266-275.

https://doi.org/10.18502/sjms.v14i4.5905

19. Zubair KU, Shah AH, Fawwad A, Sabir R, Butt A. Frequency of urinary tract infection and antibiotic sensitivity of uropathogens in patients with diabetes. Pak J Med Sci 2019; 35(6): 1664. https://dx.doi.org/10.12669%2Fpjms.35.6.115

20. Gajdács M, Burián K, Terhes G. Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot. Antibiotics 2019; 8(3): 143. https://doi.org/10.3390/antibiotics8030143